173 related articles for article (PubMed ID: 25405322)
1. Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease.
Brüggen MC; Petzelbauer P; Greinix H; Contassot E; Jankovic D; French L; Socié G; Rabitsch W; Kuzmina Z; Kalhs P; Knobler R; Stingl G; Stary G
J Invest Dermatol; 2015 Apr; 135(4):999-1006. PubMed ID: 25405322
[TBL] [Abstract][Full Text] [Related]
2. Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease.
Brüggen MC; Klein I; Greinix H; Bauer W; Kuzmina Z; Rabitsch W; Kalhs P; Petzelbauer P; Knobler R; Stingl G; Stary G
Blood; 2014 Jan; 123(2):290-9. PubMed ID: 24255916
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review.
Bhattarai A; Shah S; Yadav R; Dhakal G; Neupane R; Paudel S; Bhandari P; Abu Serhan H; Sah R; Sah S; Barboza JJ
Hematology; 2024 Dec; 29(1):2293497. PubMed ID: 38112182
[TBL] [Abstract][Full Text] [Related]
4. [A preliminary study on clinical diagnostic value of plasma elafin in skin acute graft-versus-host disease].
Luo CW; Weng JY; Wu SJ; Lu ZS; Guo R; Du X
Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):922-5. PubMed ID: 23363749
[TBL] [Abstract][Full Text] [Related]
5. Elafin as a Predictive Biomarker of Acute Skin Graft-
Solán L; Carbonell D; Muñiz P; Dorado N; Landete E; Chicano-Lavilla M; Anguita J; Gayoso J; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I
Front Immunol; 2021; 12():516078. PubMed ID: 33679728
[TBL] [Abstract][Full Text] [Related]
6. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.
Nomura S; Ishii K; Fujita S; Nakaya A; Satake A; Ito T
Transpl Immunol; 2017 Aug; 43-44():27-32. PubMed ID: 28687251
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
8. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
Min SS; Mehra V; Clay J; Cross GF; Douiri A; Dew T; Basu TN; Potter V; Ceesay MM; Pagliuca A; Sherwood RA; Vincent RP
J Clin Pathol; 2017 Oct; 70(10):886-890. PubMed ID: 28450387
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients.
Fischer A; Jakubowski AA; Lacouture ME; Hollmann TJ; Drucker AM; Maloy M; Prockop S; Querfeld C; Busam KJ; Pulitzer MP
Am J Dermatopathol; 2015 Jul; 37(7):523-9. PubMed ID: 26091510
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA155 is increased in patients with acute graft-versus-host disease.
Xie LN; Zhou F; Liu XM; Fang Y; Yu Z; Song NX; Kong FS
Clin Transplant; 2014 Mar; 28(3):314-23. PubMed ID: 24494749
[TBL] [Abstract][Full Text] [Related]
11. [A comparison of clinical characteristics and prognosis of adult acute graft-versus-host disease between human leukocyte antigen- identical and -mismatched allogeneic hematopoietic stem cell transplantation].
Zhao X; Xu L; Liu D; Han T; Wang Y; Zhang X; Yan C; Chen H; Han W; Wang J; Zhao T; Li Y; Zhang B; Zhao X; Liu K; Huang X
Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):35-9. PubMed ID: 24674726
[TBL] [Abstract][Full Text] [Related]
12. Utility of tissue elafin as an immunohistochemical marker for diagnosis of acute skin graft-versus-host disease: a pilot study.
Mahabal GD; George L; Peter D; Bindra M; Thomas M; Srivastava A; Mathews V; George B; Pulimood SA
Clin Exp Dermatol; 2019 Mar; 44(2):161-168. PubMed ID: 29882232
[TBL] [Abstract][Full Text] [Related]
13. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.
Hillen U; Häusermann P; Massi D; Janin A; Wolff D; Lawitschka A; Greinix H; Meyer R; Ziemer M
J Eur Acad Dermatol Venereol; 2015 May; 29(5):948-54. PubMed ID: 25265987
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of eosinophils in acute graft-versus-host disease compared with drug hypersensitivity reactions.
Weaver J; Bergfeld WF
Am J Dermatopathol; 2010 Feb; 32(1):31-4. PubMed ID: 19730082
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft-versus-host disease.
Wegner J; Weidenthaler-Barth B; Engelbert J; Knothe M; Braun C; Helbig D; Sacher C; Kreft A; Wagner EM; Ziemer M; Meyer RG; von Stebut E
Exp Dermatol; 2021 Dec; 30(12):1814-1819. PubMed ID: 34223669
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
Zewde MG; Morales G; Gandhi I; Özbek U; Aguayo-Hiraldo P; Ayuk F; Baez J; Chanswangphuwana C; Choe H; DeFilipp Z; Etra A; Grupp S; Hexner EO; Hogan W; Javorniczky NR; Kasikis S; Kitko CL; Kowalyk S; Meedt E; Merli P; Nakamura R; Qayed M; Reshef R; Rösler W; Schechter T; Weber D; Wölfl M; Yanik G; Young R; Levine JE; Ferrara JLM; Chen YB
Transplant Cell Ther; 2021 Dec; 27(12):988.e1-988.e7. PubMed ID: 34474163
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.
Cho BS; Lee SE; Song HH; Lee JH; Yahng SA; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1136-43. PubMed ID: 22261380
[TBL] [Abstract][Full Text] [Related]
18. Limited utility of plasma elafin as a biomarker for skin graft-versus-host disease following allogeneic stem cell transplantation.
George L; Mahabal G; Mohanan E; Balasubramanian P; Peter D; Pulimood S; Lakshmi K; Jeyaseelan L; Abraham A; Srivastava A; Mathews V; George B
Clin Exp Dermatol; 2021 Dec; 46(8):1482-1487. PubMed ID: 34081805
[TBL] [Abstract][Full Text] [Related]
19. Numerical impairment of nestin(+) bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML.
Medinger M; Krenger W; Jakab A; Halter J; Buser A; Bucher C; Passweg J; Tzankov A
Bone Marrow Transplant; 2015 Nov; 50(11):1453-8. PubMed ID: 26301968
[TBL] [Abstract][Full Text] [Related]
20. Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response.
Fondi C; Nozzoli C; Benemei S; Baroni G; Saccardi R; Guidi S; Nicoletti P; Bartolozzi B; Pimpinelli N; Santucci M; Bosi A; Massi D
Biol Blood Marrow Transplant; 2009 Aug; 15(8):938-47. PubMed ID: 19589483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]